Display options
Cite
Hrad V, Abebe Y, Ali SH, et al. Risk and Surveillance of Cancers in Primary Biliary Tract Disease. Gastroenterol Res Pract. 2016;2016:3432640doi: 10.1155/2016/3432640.
Hrad, V., Abebe, Y., Ali, S. H., Velgersdyk, J., Al Hallak, M., & Imam, M. (2016). Risk and Surveillance of Cancers in Primary Biliary Tract Disease. Gastroenterology research and practice, 20163432640. https://doi.org/10.1155/2016/3432640
Hrad, Valery, et al. "Risk and Surveillance of Cancers in Primary Biliary Tract Disease." Gastroenterology research and practice vol. 2016 (2016): 3432640. doi: https://doi.org/10.1155/2016/3432640
Hrad V, Abebe Y, Ali SH, Velgersdyk J, Al Hallak M, Imam M. Risk and Surveillance of Cancers in Primary Biliary Tract Disease. Gastroenterol Res Pract. 2016;2016:3432640. doi: 10.1155/2016/3432640. Epub 2016 Jun 19. PMID: 27413366; PMCID: PMC4930812.
Copy Download .nbib Format: NLM
Share it on

Gastroenterol Res Pract. 2016;2016:3432640. doi: 10.1155/2016/3432640. Epub 2016 Jun 19.

Risk and Surveillance of Cancers in Primary Biliary Tract Disease.

Gastroenterology research and practice

Valery Hrad, Yoftahe Abebe, Syed Haris Ali, Jared Velgersdyk, Mohammed Al Hallak, Mohamad Imam

Affiliations

  1. Department of Internal Medicine, University of North Dakota, Fargo, ND 58102, USA.
  2. Department of General Internal Medicine, MD Anderson Cancer Center, Houston, TX 77030, USA.

PMID: 27413366 PMCID: PMC4930812 DOI: 10.1155/2016/3432640

Abstract

Primary biliary diseases have been associated in several studies with various malignancies. Understanding the risk and optimizing surveillance strategy of these malignancies in this specific subset of patients are an important facet of clinical care. For instance, primary sclerosing cholangitis is associated with an increased risk for cholangiocarcinoma (which is very challenging to diagnose) and when IBD is present for colorectal cancer. On the other hand, primary biliary cirrhosis patients with cirrhosis or not responding to 12 months of ursodeoxycholic acid therapy are at increased risk of hepatocellular carcinoma. In this review we will discuss in detail the risks and optimal surveillance strategies for patients with primary biliary diseases.

References

  1. Gastrointest Endosc. 2006 May;63(6):741-5 - PubMed
  2. Clin Ter. 2015 ;166(2):e122-5 - PubMed
  3. Hepatology. 2011 Mar;53(3):875-84 - PubMed
  4. Clin Gastroenterol Hepatol. 2014 Oct;12(10):1733-8 - PubMed
  5. Scand J Gastroenterol. 2002 Oct;37(10):1205-11 - PubMed
  6. Ital J Gastroenterol. 1993 Nov-Dec;25(9):473-6 - PubMed
  7. Can J Gastroenterol. 2013 Jul;27(7):417-23 - PubMed
  8. Hepatology. 1989 Jul;10(1):39-43 - PubMed
  9. Jpn J Pharmacol. 1976 Dec;26(6):760-2 - PubMed
  10. Hepatology. 1995 Nov;22(5):1404-8 - PubMed
  11. J Hepatol. 2002 Mar;36(3):321-7 - PubMed
  12. Acta Haematol. 1985;73(2):104-5 - PubMed
  13. Hepatology. 1992 Dec;16(6):1404-8 - PubMed
  14. Gastrointest Endosc. 2014 May;79(5):780-2 - PubMed
  15. Hepatology. 2010 Jun;51(6):2193-213 - PubMed
  16. Dig Dis Sci. 2000 Oct;45(10):1944-8 - PubMed
  17. Hepatology. 1988 Nov-Dec;8(6):1679-83 - PubMed
  18. Int J Clin Exp Pathol. 2014 May 15;7(6):3272-9 - PubMed
  19. Eur J Gastroenterol Hepatol. 1999 May;11(5):569-73 - PubMed
  20. Hepatology. 2012 Oct;56(4):1409-17 - PubMed
  21. Hepatology. 2013 Apr;57(4):1607-19 - PubMed
  22. PLoS One. 2013 Oct 30;8(10):e77433 - PubMed
  23. Semin Liver Dis. 1994 May;14(2):109-14 - PubMed
  24. J Diabetes Complications. 2000 Mar-Apr;14(2):116-20 - PubMed
  25. Hepatology. 2002 Jul;36(1):150-5 - PubMed
  26. Gastrointest Endosc. 2011 Oct;74(4):805-14 - PubMed
  27. Gastrointest Endosc. 2002 Jul;56(1):48-54 - PubMed
  28. J Hepatol. 2000 Oct;33(4):537-42 - PubMed
  29. World J Gastrointest Oncol. 2013 Jul 15;5(7):147-58 - PubMed
  30. J Clin Oncol. 2008 Dec 20;26(36):5918-22 - PubMed
  31. Scand J Gastroenterol. 2015 Feb;50(2):217-23 - PubMed
  32. Rheumatol Int. 2002 Nov;22(6):233-7 - PubMed
  33. Gastrointest Endosc. 2014 Jun;79(6):943-950.e3 - PubMed
  34. Aliment Pharmacol Ther. 2006 Oct 15;24(8):1197-205 - PubMed
  35. Am J Gastroenterol. 2008 Aug;103(8):1944-51 - PubMed
  36. Gut. 2001 Mar;48(3):430-4 - PubMed
  37. Dig Dis Sci. 2010 Nov;55(11):3218-23 - PubMed
  38. Hepatology. 2001 Dec;34(6):1083-8 - PubMed
  39. Gut. 2016 Feb;65(2):321-9 - PubMed
  40. Hepatology. 1994 Jul;20(1 Pt 1):101-4 - PubMed
  41. Oncol Rep. 2014 Jun;31(6):2515-24 - PubMed
  42. Am J Gastroenterol. 2002 May;97(5):1138-42 - PubMed
  43. J Crohns Colitis. 2014 Sep;8(9):956-63 - PubMed
  44. Hepatology. 2008 Oct;48(4):1106-17 - PubMed
  45. Eur J Gastroenterol Hepatol. 2007 Jul;19(7):607-9 - PubMed
  46. Cancer. 1995 Jan 1;75(1 Suppl):171-90 - PubMed
  47. Hepatology. 2001 Jun;33(6):1353-7 - PubMed
  48. Gastroenterology. 2013 Sep;145(3):521-36 - PubMed
  49. Dig Dis Sci. 2005 Sep;50(9):1734-40 - PubMed
  50. World J Hepatol. 2015 Apr 18;7(5):799-805 - PubMed
  51. Br Med J (Clin Res Ed). 1985 Dec 7;291(6509):1597-8 - PubMed
  52. Gut. 1996 Apr;38(4):610-5 - PubMed
  53. Dig Dis Sci. 2015 Jul;60(7):2150-7 - PubMed
  54. Hepatology. 2000 Jan;31(1):7-11 - PubMed
  55. Hepatology. 2008 Jan;47(1):90-6 - PubMed
  56. Gastrointest Endosc. 2011 Nov;74(5):961-8 - PubMed
  57. J Hepatol. 2011 Feb;54(2):374-85 - PubMed
  58. Dig Dis Sci. 2011 Feb;56(2):578-85 - PubMed
  59. Spat Spatiotemporal Epidemiol. 2015 Jul-Oct;14-15:1-8 - PubMed
  60. Am J Epidemiol. 2014 Feb 15;179(4):492-8 - PubMed
  61. Gut. 2005 Jan;54(1):91-6 - PubMed
  62. Dig Surg. 2008;25(2):126-32 - PubMed
  63. Leuk Lymphoma. 2001 Mar;41(1-2):207-12 - PubMed
  64. Inflamm Bowel Dis. 2007 Nov;13(11):1401-7 - PubMed
  65. Can J Gastroenterol. 2013;27(5):273-80 - PubMed
  66. Gastrointest Endosc. 2014 May;79(5):783-9 - PubMed
  67. Hepatology. 2011 Nov;54(5):1842-52 - PubMed
  68. Hum Pathol. 1985 Jul;16(7):719-26 - PubMed
  69. BJPsych Bull. 2015 Dec;39(6):302-4 - PubMed
  70. Am J Gastroenterol. 2006 Dec;101(12):2731-6 - PubMed
  71. Hepatology. 2015 May;61(5):1651-9 - PubMed
  72. PLoS One. 2015 Oct 02;10(10):e0139305 - PubMed
  73. Hum Pathol. 2014 Sep;45(9):1797-804 - PubMed
  74. Hepatol Int. 2014 Apr;8(2):266-74 - PubMed
  75. Am J Med. 1984 Jun;76(6):1075-8 - PubMed
  76. J Hepatol. 2010 Aug;53(2):313-7 - PubMed
  77. Am J Gastroenterol. 2015 Feb;110(2):299-309 - PubMed
  78. Eur J Gastroenterol Hepatol. 2012 Jun;24(6):656-64 - PubMed
  79. Semin Liver Dis. 2015 Nov;35(4):392-401 - PubMed
  80. Hepatology. 2009 Oct;50(4):1162-8 - PubMed
  81. J Hepatol. 2004 Mar;40(3):472-7 - PubMed
  82. J Hepatol. 2009 Feb;50(2):388-93 - PubMed
  83. Gastrointest Endosc Clin N Am. 2015 Oct;25(4):677-90 - PubMed
  84. Dig Dis Sci. 2016 Jun;61(6):1757-62 - PubMed
  85. Cancer Res. 2000 Jan 1;60(1):184-90 - PubMed
  86. Scand J Gastroenterol. 2015 Apr;50(4):423-8 - PubMed
  87. Clin Gastroenterol Hepatol. 2010 Jun;8(6):530-4 - PubMed
  88. Eur J Gastroenterol Hepatol. 2008 Jan;20(1):5-9 - PubMed
  89. Endoscopy. 2012 Mar;44(3):251-7 - PubMed
  90. Cancer Res. 2014 Feb 15;74(4):1005-10 - PubMed
  91. Scand J Gastroenterol. 2014 Oct;49(10):1237-44 - PubMed
  92. Hepatology. 1999 Jul;30(1):325-32 - PubMed
  93. J Hepatol. 2000 Dec;33(6):873-7 - PubMed
  94. Hepatology. 1995 Apr;21(4):959-62 - PubMed
  95. CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30 - PubMed
  96. Hepatology. 2010 Feb;51(2):660-78 - PubMed
  97. Dig Dis Sci. 2013 Jul;58(7):2068-74 - PubMed
  98. Hepatology. 2008 Sep;48(3):863-70 - PubMed
  99. Hepatogastroenterology. 2014 May;61(131):567-73 - PubMed
  100. Hepatology. 2015 Feb;61(2):627-38 - PubMed
  101. Gastrointest Endosc. 2014 May;79(5):773-779.e2 - PubMed
  102. Postgrad Med J. 2008 May;84(991):228-37 - PubMed
  103. Turk J Gastroenterol. 2011 Feb;22(1):73-6 - PubMed
  104. Aliment Pharmacol Ther. 2007 Dec;26 Suppl 2:47-52 - PubMed

Publication Types